TXG logo

10x Genomics (TXG)

Profile

Full Name

10x Genomics, Inc.

Ticker Symbol

TXG

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

September 12, 2019

Indexes

Not included

Website

http://www.10xgenomics.com

Employees

1306

Key Details

Price

$9.34(+5.36%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$610.78M(-1.28% YoY)

Annual EPS

-$1.52(+30.28% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.34
    TXG price is $9.34

    30-Day Relative Volume

    1.12
    TXG 30-day relative volume is 1.12

    Price Performance

    Price Most recent change

    +5.36%
    TXG price was up +5.36% on May 29, 2025

    Price YTD change

    -34.99%
    TXG price is down -34.99% since January 1st

    Price 1-year change

    -58.34%
    TXG price is down -58.34% year-on-year

    Price 3-year change

    -82.38%
    TXG price is down -82.38% over the past 3 years

    Price Range

    Price All-time high

    $208.99
    TXG price is currently -95.53% below its historical high of $208.99

    Price 3-year low

    $6.78
    TXG price is currently +37.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.15B
    TXG market capitalization is $1.15 billion

    Market cap 3-year change

    -80.87%
    TXG market capitalization is down -80.87% over the past 3 years

    Market cap All-time high

    $22.11B
    TXG market capitalization is currently -94.80% below its historical high of $22.11 billion

    Market cap sector rank

    77.19%
    TXG market capitalization is higher than 77.19% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.86%
    TXG shares outstanding is up +2.86% year-on-year

    Shares Outstanding 3-Year Change

    +8.61%
    TXG shares outstanding is up +8.61% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.87
    TXG beta is 1.87

    200-day SMA

    $14.45
    TXG price is currently -35.41% below its 200-day simple moving average

    50-day SMA

    $8.65
    TXG price is currently +7.87% above its 50-day simple moving average

    RSI

    56.34
    TXG 14-day relative strength index is 56.34

    Volume

    1.12
    TXG 30-day relative volume is 1.12

    ATR

    $0.54
    TXG average true range is $0.54

    10-day Historical Volatility

    73.24%
    TXG 10-day historical volatility is 73.24%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $610.78M
    TXG annual revenue is $610.78 million

    Revenue Analysts estimate

    $590.36M
    TXG annual revenue is currently +3.46% higher than the consensus analysts' forecast

    Revenue 1-year change

    -1.28%
    TXG annual revenue is down -1.28% year-on-year

    Revenue Sector rank

    75.65%
    TXG annual revenue is higher than 75.65% of companies in Healthcare sector

    EPS

    EPS

    -$1.52
    TXG annual earnings per share is -$1.52

    EPS Analysts estimate

    -$0.08
    TXG annual earnings per share is currently +1800.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +30.28%
    TXG annual earnings per share is up +30.28% year-on-year

    EPS Sector rank

    45.16%
    TXG annual earnings per share is higher than 45.16% of companies in Healthcare sector

    Profit

    Gross profit

    $414.48M
    TXG annual gross profit is $414.48 million

    Gross margin

    67.86%
    TXG annual gross profit margin is 67.86%

    Operating profit

    -$194.56M
    TXG annual operating income is -$194.56 million

    Operating margin

    -31.85%
    TXG annual operating profit margin is -31.85%

    Net income

    -$182.63M
    TXG annual net profit is -$182.63 million

    Net margin

    -29.90%
    TXG annual net profit margin is -29.90%

    Expenses

    Total expenses

    $805.34M
    TXG annual total expenses is $805.34 million

    Operating expenses

    $609.04M
    TXG annual total operating expenses is $609.04 million

    Cost of goods sold

    $196.30M
    TXG annual cost of goods sold is $196.30 million

    Selling, general & administrative expenses

    $344.34M
    TXG annual SGA is $344.34 million

    Depreciation and amortization

    $43.71M
    TXG annual depreciation & amortization is $43.71 million

    Interest expense

    $4000.00
    TXG annual interest expense is $4000.00

    Income tax

    $4.93M
    TXG annual income tax is $4.93 million

    EBIT & EBITDA

    EBIT

    -$177.70M
    TXG annual earnings before interest & taxes is -$177.70 million

    EBITDA

    -$133.99M
    TXG annual EBITDA is -$133.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $918.64M
    TXG annual total assets is $918.64 million

    Non current assets

    $334.25M
    TXG annual long term assets is $334.25 million

    Current assets

    $584.39M
    TXG annual total current assets is $584.39 million

    Cash and cash equivalents

    $344.07M
    TXG annual cash & cash equivalents is $344.07 million

    Accounts receivable

    $87.86M
    TXG annual accounts receivable is $87.86 million

    Inventory

    $83.11M
    TXG annual inventory is $83.11 million

    Liabilities

    Total liabilities

    $208.50M
    TXG annual total liabilities is $208.50 million

    Long term liabilities

    $90.87M
    TXG annual total long term liabilities is $90.87 million

    Current liabilities

    $117.63M
    TXG annual total current liabilities is $117.63 million

    Accounts payable

    $12.91M
    TXG annual accounts payable is $12.91 million

    Debt

    Total debt

    $82.61M
    TXG annual total debt is $82.61 million

    Total debt 1-year change

    -13.38%
    TXG annual total debt is down -13.38% year-on-year

    Long term debt

    $73.33M
    TXG annual long term debt is $73.33 million

    Short term debt

    $9.29M
    TXG annual short term debt is $9.29 million

    Equity & Capital

    Shareholders equity

    $710.13M
    TXG annual stockholders equity is $710.13 million

    Book value

    $710.13M
    TXG annual book value is $710.13 million

    Retained earnings

    -$1.47B
    TXG annual retained earnings is -$1.47 billion

    Working capital

    $466.75M
    TXG annual working capital is $466.75 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $6.66M
    TXG annual cash flow from operations is $6.66 million

    Cash from operations 1-year change

    +143.85%
    TXG annual cash flow from operations is up +143.85% year-on-year

    Cash from investing

    -$32.63M
    TXG annual cash flow from investing activities is -$32.63 million

    Cash from investing 1-year change

    -124.44%
    TXG annual cash flow from investing activities is down -124.44% year-on-year

    Cash from financing

    $10.91M
    TXG annual cash flow from financing activities is $10.91 million

    Cash from financing 1-year change

    -20.16%
    TXG annual cash flow from financing activities is down -20.16% year-on-year

    CAPEX

    CAPEX

    $13.39M
    TXG annual capital expenditures is $13.39 million

    CAPEX 1-year change

    -72.96%
    TXG annual capital expenditures is down -72.96% year-on-year

    Free Cash Flow

    Free cash flow

    -$6.73M
    TXG annual free cash flow is -$6.73 million

    Free cash flow 1-year change

    +89.6%
    TXG annual free cash flow is up +89.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    67.86%
    TXG annual gross profit margin is 67.86%

    Operating margin

    -31.85%
    TXG annual operating profit margin is -31.85%

    Net margin

    -29.90%
    TXG annual net profit margin is -29.90%

    ROA & ROE

    ROA

    -19.39%
    TXG annual return on assets is -19.39%

    ROE

    -25.17%
    TXG annual return on equity is -25.17%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TXG price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TXG price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.63
    TXG price to book ratio is 1.63

    PB ratio Sector rank

    52.79%
    TXG price to book ratio is higher than 52.79% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.84
    TXG price to sales ratio is 1.84

    PS ratio Sector rank

    40.53%
    TXG price to sales ratio is higher than 40.53% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $852.47M
    TXG enterprise value is $852.47 million

    Enterprise value Sector rank

    74.03%
    TXG enterprise value is higher than 74.03% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.65
    TXG EV/EBITDA is -7.65

    EV/EBITDA Sector rank

    15.98%
    TXG EV/EBITDA is higher than 15.98% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.97
    TXG annual current ratio is 4.97

    Quick ratio

    4.26
    TXG annual quick ratio is 4.26

    Leverage

    Debt to equity

    0.00
    TXG annual debt to equity ratio is 0.00

    Interest coverage ratio

    -44.42K
    TXG annual interest coverage ratio is -44.42 thousand

    Risk & Stability

    Piotroski F-Score

    6
    TXG piotroski f-score is 6

    Altman Z-Score

    1.71
    TXG altman z-score is 1.71

    Analyst ratings

    Recent major analysts updates

    May 19, 25 Morgan Stanley
    Overweight
    May 15, 25 Stephens & Co.
    Overweight
    May 13, 25 UBS
    Neutral
    May 12, 25 Goldman Sachs
    Sell
    May 12, 25 Canaccord Genuity
    Buy
    May 9, 25 JP Morgan
    Neutral
    Apr 10, 25 Barclays
    Overweight
    Mar 4, 25 Citigroup
    Buy
    Feb 14, 25 Morgan Stanley
    Overweight
    Feb 14, 25 Barclays
    Overweight

    Institutional Ownership

    Screeners with TXG included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for 10x Genomics?
    • Does 10x Genomics pay dividends?
    • What sector is 10x Genomics in?
    • What industry is 10x Genomics in?
    • What country is 10x Genomics based in?
    • When did 10x Genomics go public?
    • Is 10x Genomics in the S&P 500?
    • Is 10x Genomics in the NASDAQ 100?
    • Is 10x Genomics in the Dow Jones?
    • When was 10x Genomics's last earnings report?
    • When does 10x Genomics report earnings?
    • Should I buy 10x Genomics stock now?

    What is the ticker symbol for 10x Genomics?

    The ticker symbol for 10x Genomics is NASDAQ:TXG

    Does 10x Genomics pay dividends?

    No, 10x Genomics does not pay dividends

    What sector is 10x Genomics in?

    10x Genomics is in the Healthcare sector

    What industry is 10x Genomics in?

    10x Genomics is in the Health Information Services industry

    What country is 10x Genomics based in?

    10x Genomics is headquartered in United States

    When did 10x Genomics go public?

    10x Genomics's initial public offering (IPO) was on September 12, 2019

    Is 10x Genomics in the S&P 500?

    No, 10x Genomics is not included in the S&P 500 index

    Is 10x Genomics in the NASDAQ 100?

    No, 10x Genomics is not included in the NASDAQ 100 index

    Is 10x Genomics in the Dow Jones?

    No, 10x Genomics is not included in the Dow Jones index

    When was 10x Genomics's last earnings report?

    10x Genomics's most recent earnings report was on May 8, 2025

    When does 10x Genomics report earnings?

    The next expected earnings date for 10x Genomics is Aug 8, 2025

    Should I buy 10x Genomics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page